Evidence map›Paper›PMID 25048575›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2014

Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model.

Bálint Botz, Kata Bölcskei, László Kereskai, Miklós Kovács, Tamás Németh, Krisztián Szigeti, Ildikó Horváth, Domokos Máthé, Noémi Kovács, Hitoshi Hashimoto and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Protective Effects of PACAP in Peripheral Organs.Frontiers in endocrinology · 2020
    Review
  9. Article
  10. Article
  11. Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. PACAP38 and PACThe journal of headache and pain · 2018
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Bálint BotzDepartment of Pharmacology and Pharmacotherapy, University of Pécs Medical School, and Molecular Pharmacology Research Team, János Szentágothai Research Centre, University of Pécs, Pécs, Hungary.
Kata Bölcskei
László Kereskai
Miklós Kovács
Tamás Németh
Krisztián Szigeti
Ildikó Horváth
Domokos Máthé
Noémi Kovács
Hitoshi Hashimoto
Dóra Reglődi
János Szolcsányi
Erika Pintér
Attila Mócsai
Zsuzsanna Helyes
University of Pecs · HUSemmelweis University · HUMontavid Thermodynamic Research Group · HUOsaka University of Pharmaceutical Sciences · JP

Funding

European Research Council 206283Wellcome Trust 087782
6 · The paper itself

Abstract

objectivePituitary adenylate cyclase-activating polypeptide (PACAP) expressed in capsaicin-sensitive sensory neurons and immune cells has divergent functions in inflammatory and pain processes. This study was undertaken to investigate the involvement of PACAP in a mouse model of rheumatoid arthritis.

methodsArthritis was induced in PACAP(-/-) and wild-type (PACAP(+/+) ) mice by K/BxN serum transfer. General features of the disease were investigated by semiquantitative scoring, plethysmometry, and histopathologic analysis. Mechano- and thermonociceptive thresholds and motor functions were also evaluated. Metabolic activity was assessed by positron emission tomography. Bone morphology was measured by in vivo micro-computed tomography, myeloperoxidase activity and superoxide production by bioluminescence imaging with luminol and lucigenin, respectively, and vascular permeability by fluorescent indocyanine green dye study.

resultsPACAP(+/+) mice developed notable joint swelling, reduced grasping ability, and mechanical (but not thermal) hyperalgesia after K/BxN serum transfer. In PACAP(-/-) mice clinical scores and edema were significantly reduced, and mechanical hyperalgesia and motor impairment were absent, throughout the 2-week period of observation. Metabolic activity and superoxide production increased in the tibiotarsal joints of wild-type mice but were significantly lower in PACAP(-/-) animals. Myeloperoxidase activity in the ankle joints of PACAP(-/-) mice was significantly reduced in the early phase of arthritis, but increased in the late phase. Synovial hyperplasia was also significantly increased, and progressive bone spur formation was observed in PACAP-deficient mice only.

conclusionIn PACAP-deficient mice with serum-transfer arthritis, joint swelling, vascular leakage, hyperalgesia, and early inflammatory cell accumulation are reduced; in the later phase of the disease, immune cell function and bone neoformation are increased. Elucidation of the underlying pathways of PACAP activity may open promising new avenues for development of therapy in inflammatory arthritis.

Indexed as

AnimalsArthritis, ExperimentalHyperalgesiaInflammationMiceMice, KnockoutPain MeasurementPituitary Adenylate Cyclase-Activating PolypeptideSensory Receptor CellsSeverity of Illness IndexAdcyap1 protein, mousePituitary Adenylate Cyclase-Activating Polypeptide

Identifiers

PMID25048575
PMCPMC4320777
OpenAlexW1519916460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.